Zeng A, Yin Y, Xu Z, Abuduwayiti A, et al. Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD). BMC Cancer 2024;24:396.
PMID: 38553708